A Study to Evaluate the Safety and Immunogenicity of Ad5-105K in Adults Aged 18 to 49 Years
Clinical trial NCT06732583 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06732583
- Sponsor
- CanSino Biologics Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-13
- Primary completion
- 2026-08-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.